109 related articles for article (PubMed ID: 32424163)
1. Generation of a conditional transgenic mouse model expressing human Phospholipase A2 Receptor 1.
Jaber S; Goehrig D; Bertolino P; Massemin A; Bihl F; Chabry J; Lambeau G; Vindrieux D; Bernard D
Sci Rep; 2020 May; 10(1):8190. PubMed ID: 32424163
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy.
Tomas NM; Schnarre A; Dehde S; Lucas R; Hermans-Borgmeyer I; Kretz O; Koellner SMS; Wiech T; Koch-Nolte F; Seifert L; Huber TB; Zahner G
Kidney Int; 2023 Nov; 104(5):916-928. PubMed ID: 37598854
[TBL] [Abstract][Full Text] [Related]
3. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.
Meyer-Schwesinger C; Tomas NM; Dehde S; Seifert L; Hermans-Borgmeyer I; Wiech T; Koch-Nolte F; Huber TB; Zahner G
Kidney Int; 2020 May; 97(5):913-919. PubMed ID: 32033781
[TBL] [Abstract][Full Text] [Related]
4. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
Tomas NM; Dehde S; Meyer-Schwesinger C; Huang M; Hermans-Borgmeyer I; Maybaum J; Lucas R; von der Heide JL; Kretz O; Köllner SMS; Seifert L; Huber TB; Zahner G
Kidney Int; 2023 Feb; 103(2):297-303. PubMed ID: 36191868
[TBL] [Abstract][Full Text] [Related]
5. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
Sukocheva O; Menschikowski M; Hagelgans A; Yarla NS; Siegert G; Reddanna P; Bishayee A
Semin Cancer Biol; 2019 Jun; 56():116-127. PubMed ID: 29104026
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
[TBL] [Abstract][Full Text] [Related]
7. Identification of Epithelial Phospholipase A
Nolin JD; Ogden HL; Lai Y; Altemeier WA; Frevert CW; Bollinger JG; Naika GS; Kicic A; Stick SM; Lambeau G; Henderson WR; Gelb MH; Hallstrand TS
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):825-836. PubMed ID: 27448109
[TBL] [Abstract][Full Text] [Related]
8. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
10. R/L, a double reporter mouse line that expresses luciferase gene upon Cre-mediated excision, followed by inactivation of mRFP expression.
Jia J; Lin X; Lin X; Lin T; Chen B; Hao W; Cheng Y; Liu Y; Dian M; Yao K; Xiao D; Gu W
Genome; 2016 Oct; 59(10):816-826. PubMed ID: 27643679
[TBL] [Abstract][Full Text] [Related]
11. [New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy].
Girard CA; Seitz-Polski B; Dolla G; Augert A; Vindrieux D; Bernard D; Lambeau G
Med Sci (Paris); 2014 May; 30(5):519-25. PubMed ID: 24939538
[TBL] [Abstract][Full Text] [Related]
12. PLA2R1: expression and function in cancer.
Bernard D; Vindrieux D
Biochim Biophys Acta; 2014 Aug; 1846(1):40-4. PubMed ID: 24667060
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease.
Beaulieu D; Attwe A; Breau M; Lipskaia L; Marcos E; Born E; Huang J; Abid S; Derumeaux G; Houssaini A; Maitre B; Lefevre M; Vienney N; Bertolino P; Jaber S; Noureddine H; Goehrig D; Vindrieux D; Bernard D; Adnot S
Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33509955
[TBL] [Abstract][Full Text] [Related]
14. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.
Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D
Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637
[TBL] [Abstract][Full Text] [Related]
15. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Expression Changes and Promoter Methylation of PLA2R1 in Tissues of Breast Cancer Patients.
Mitwally N; Yousef E; Abd Al Aziz A; Taha M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751713
[TBL] [Abstract][Full Text] [Related]
17. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
Front Immunol; 2019; 10():1809. PubMed ID: 31447839
[TBL] [Abstract][Full Text] [Related]
18. Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.
Lateb M; Ouahmi H; Payré C; Brglez V; Zorzi K; Dolla G; Zaidan M; Boyer-Suavet S; Knebelmann B; Crépin T; Courivaud C; Jourde-Chiche N; Esnault V; Lambeau G; Seitz-Polski B
J Immunol Res; 2019; 2019():1324804. PubMed ID: 32083137
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
20. PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during aging.
Huna A; Griveau A; Vindrieux D; Jaber S; Flaman JM; Goehrig D; Azzi L; Médard JJ; Djebali S; Hernandez-Vargas H; Dante R; Payen L; Marvel J; Bertolino P; Aubert S; Dubus P; Bernard D
Cell Death Dis; 2021 Feb; 12(2):190. PubMed ID: 33594040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
